Enhancing chemotherapy sensitivity by targeting PcG via the ATM/p53 pathway.
Shu-Bin Gao(Xiamen University), Lixiang Xue(Peking University), Yue Zhao(Zhejiang Cancer Hospital), Shi Shu(Peking University), Guang‐Hui Jin(Xiamen University), Huan Qiu(Rutgers, The State University of New Jersey), Shuhua Wei(Peking University), Ling-Yu Zhu(Xiamen University), Chang-Bao Pan(Xiamen University), Kang‐Li Li(Guangdong-Hongkong-Macau Joint Laboratory of Collaborative Innovation for Environmental Quality)
PubMed
January 1, 2017
Cited by 18
Related Papers
Insights into the red algae and eukaryotic evolution from the genome of <i>Porphyra umbilicalis</i> (Bangiophyceae, Rhodophyta)
|Proceedings of the National Academy of Sciences|2017|309
IL-7: A promising adjuvant ensuring effective T cell responses and memory in combination with cancer vaccines?
|Frontiers in Immunology|2022|72
EZH2 Represses Target Genes through H3K27-Dependent and H3K27-Independent Mechanisms in Hepatocellular Carcinoma
|Molecular Cancer Research|2014|69